Karla Ann Henning

USPTO Granted Patents = 22 (Patent Applications = 17)

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 11.2

ph-index = 7

Forward Citations = 135(Granted Patents)

Location History:

Redwood City, CA (US) (2023)
Milpitas, CA (US) (2016 - 2024)

Company Filing History:

20 out of 3,684

Bristol-myers Squibb Compnay

Bolt Biotherapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12372536 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof (2025-07-29),

2. 12325750 - Anti-Dectin-2 antibodies and methods of using (2025-06-10),

3. 12077584 - Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) (2024-09-03),

4. 11981734 - Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) (2024-05-14),

5. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

6. 11753474 - Anti-Dectin-2 antibodies (2023-09-12),

7. 11474112 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof (2022-10-18),

8. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

9. 11352440 - Antibodies against CD73 and uses thereof (2022-06-07),

10. 11274150 - Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies (2022-03-15),

11. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

12. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

13. 10690674 - Anti-GITR antibodies for cancer diagnostics (2020-06-23),

14. 10653791 - Antibodies comprising modified heavy constant regions (2020-05-19),

15. 10501550 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-12-10),

Title: Inventor Karla Ann Henning - Revolutionizing Technology in Milpitas

Introduction: Karla Ann Henning is a pioneering inventor based in Milpitas, CA, known for her groundbreaking contributions to the field of technology.

Latest Patents: Karla Ann Henning holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Karla Ann Henning has worked with top tech companies, leading research institutions, and universities to develop cutting-edge technologies that have reshaped industries.

Collaborations: Throughout her career, Karla Ann Henning has collaborated with renowned engineers, scientists, and researchers, fostering a culture of innovation and creativity in every project she undertakes.

Conclusion: Karla Ann Henning's passion for innovation and her relentless drive to push the boundaries of technology make her a true trailblazer in the field of inventions. Her work continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.